开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2024-09-10 ms5000000014275476 来自山东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：微生物学
经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2024-08-09 ms3000001823604137 来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：小修之后编辑给拒了

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2024-06-27 学医的啊金来自江苏省

Under Evaluation 2024-06-26 12:34:30
Under Peer Review 2024-06-26 12:34:29
Under Evaluation 2024-06-14 00:54:57
Under Peer Review 2024-06-13 03:34:59
Under Evaluation 2024-06-13 03:34:59
这两个状态一直反复是什么意思啊？

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2024-07-10 ms5000001800800166 来自重庆

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：审稿人意见很中肯

61 0

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2023-09-21 浩浩Peter 来自内蒙古

缴费以后多久收到proof呀还有proof之后多久online

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2024-06-27 ms5000000350008474 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：完

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2022-05-21 可乐与红茶

请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view

91 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2023-09-22 146ee135m37暂无昵称来自广东省

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：感染
经验分享：在evaluation和peer review之间反复变换怎么回事？求解答

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2022-10-11 121e5ed5m66(暂无昵称)

偏重的研究方向：微生物
经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息

110 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224995, encodeId=cde422249953a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物学 经验分享：个人感觉投稿还是挺顺利的，可能也是文章准备充分，在专家评审时没有提出来太明显的问题，仅是语言的一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b35e8362090, createdName=ms5000000014275476, createdTime=Tue Sep 10 14:17:35 CST 2024, time=2024-09-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2219247, encodeId=3e31221924ed4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：小修之后编辑给拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89408375530, createdName=ms3000001823604137, createdTime=Fri Aug 09 11:28:19 CST 2024, time=2024-08-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211862, encodeId=e86f2211862fa, content=Under Evaluation 2024-06-26 12:34:30 Under Peer Review 2024-06-26 12:34:29 Under Evaluation 2024-06-14 00:54:57 Under Peer Review 2024-06-13 03:34:59 Under Evaluation 2024-06-13 03:34:59 这两个状态一直反复是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210922/0ef136fcae44420a84269ad817d8b318/e3b5ad7109ad4f058eabcf15a8c14dd7.jpg, createdBy=bd065227071, createdName=学医的啊金, createdTime=Thu Jun 27 01:25:25 CST 2024, time=2024-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2214306, encodeId=d0e722143062d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：审稿人意见很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63239379213, createdName=ms5000001800800166, createdTime=Wed Jul 10 19:58:47 CST 2024, time=2024-07-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2158907, encodeId=430b215890e94, content=缴费以后多久收到proof呀还有proof之后多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210223/9923927a93774b6583ab7eacbbc528da/7533d8a97713448aa1e4fdc6bbeb001a.jpg, createdBy=f70e5182015, createdName=浩浩Peter, createdTime=Thu Sep 21 14:27:14 CST 2023, time=2023-09-21, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2211993, encodeId=fdc92211993cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：完, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6cf8635284, createdName=ms5000000350008474, createdTime=Thu Jun 27 21:05:35 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1221377, encodeId=265612213e7b2, content=请问一下为什么这个投稿系统一直闲置waiting for author approval明明就选了同意，给编辑发邮件也不回，但是状态也显示一直是under peer view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/2048c339071f4300a6380be526b4b1f9/fa5023921214471ebb0ee065be3bda3d.jpg, createdBy=28ec5107211, createdName=可乐与红茶, createdTime=Sat May 21 12:19:18 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159072, encodeId=13a821590e230, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：感染 经验分享：在evaluation和peer review之间反复变换怎么回事？求解答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Fri Sep 22 09:07:43 CST 2023, time=2023-09-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093194, encodeId=d50b209319417, content=偏重的研究方向：微生物 经验分享：想问一下反复under peer review跟under evaluation是什么情况，投了一个月了，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/quB65XcY2DQkp3AOFfxy2pyMtHAl5BvpBWQCDg8Xzb52tqlVMW67v40OVI5vBTico4LML2wclZqAWibmugjtWj2Q/132, createdBy=30c62290597, createdName=121e5ed5m66(暂无昵称), createdTime=Tue Oct 11 19:55:06 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151407, encodeId=accc215140e1b, content=偏重的研究方向：天然药物 经验分享：已投，未知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fad8637479, createdName=ms8000001329067303, createdTime=Sat Aug 05 17:29:04 CST 2023, time=2023-08-05, status=1, ipAttribution=宁夏)]

2023-08-05 ms8000001329067303 来自宁夏

偏重的研究方向：天然药物
经验分享：已投，未知

107 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务